SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Neuberger High Yield Strategies Fund Inc. (NHS) trades at a trailing P/E of 9.9. Trailing earnings yield is 10.14%.
Criteria proven by this page:
- VALUE (100/100, Pass) — P/E is below market average (9.9); earnings yield beats bond yields (10.14%).
- Trailing Earnings Yield 10.14% — exceeds typical bond yields (~4.3%), making equity attractive vs fixed income.
Overall SharesGrow Score: 80/100 with 3/7 criteria passed.
SharesGrow 7-Criteria Score
✓
VALUE
100/100
Price-to-Earnings & upside
Proven by this page
~
HEALTH
67/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — NHS
Valuation Multiples
P/E (TTM)9.9
Forward P/EN/A
PEG RatioN/A
Forward PEGN/A
P/B Ratio0.00
P/S Ratio7.46
EV/EBITDA0.0
Per Share Data
EPS (TTM)$0.66
Book Value / Share$0.00
Revenue / Share$0.87
FCF / Share$0.00
Yields & Fair Value
Earnings Yield10.14%
Dividend Yield0.00%
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2016 |
$1.40 |
$29.24M |
$27.36M |
93.6% |
| 2017 |
$1.22 |
$25.82M |
$23.87M |
92.5% |
| 2018 |
$-0.16 |
$-834.75K |
$-3.09M |
- |
| 2019 |
$1.15 |
$25.51M |
$22.53M |
88.3% |
| 2020 |
$0.15 |
$6.07M |
$3.02M |
49.8% |
| 2021 |
$1.44 |
$29.51M |
$26.8M |
90.8% |
| 2022 |
$-1.72 |
$-30.38M |
$-33.49M |
- |
| 2023 |
$0.14 |
$22.35M |
$3.72M |
16.6% |
| 2024 |
$1.28 |
$41.75M |
$37.94M |
90.9% |
| 2025 |
$0.66 |
$26.72M |
$20.22M |
75.7% |
